Company intelligence / Profile preview

Grander Capital

Salt Lake City, Utah, United States

Ownership: Private
Development stage: Other

Overview

SkinTE® is a regenerative tissue product with an open investigational new drug (IND) application with the FDA. The company is pursuing the first of two pivotal studies needed to support a biologics license application (BLA) for chronic cutaneous ulcer indication

Therapeutic areas: Dermatology
Modalities: Regenerative tissue products
Industry: Biotech

Beyond the preview

Go deeper on Grander Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Grander Capital.

Explore the full profile